{"title":"癌症和植物治疗的前景:聚焦于白花蓼治疗特性的综述","authors":"P. A. Lacerda, Liliane Marinho Ottoni Costa, Guilherme Cuoghi Bellato, Lucilene Lopes-Santos, T. M. Augusto, N. Cervigne","doi":"10.15406/JCPCR.2021.12.00448","DOIUrl":null,"url":null,"abstract":"Abbreviations: PL, Polypodium leucotomos; UV, ultraviolet radiation; DNA, desoxirribonucleic acid; HPLC, high-performance liquid chromatography; CAMs, complementary and alternative medicines; MMPs, matrix metalloproteins; ECM, extracellular matrix; TIMP metallopeptidase inhibitor; TGF-β, transforming growth factor beta; ROS reactive oxygen species; MAP kinase, mitogen-activated protein kinase; NF-κB, factor nuclear kappa B; AP-1, activator protein 1; CPD, cyclobutane pyrimidine dimer, GPx4, glutathione peroxidase 4; COX-2, ciclo-oxigenase-2; 8-MOP, 8-methoxypsoralen; 5-MOP, 5-methoxypsoralen; TNFs, tumor necrosis factors; iNOS, nitric oxide synthase; PMLE, polymorphic light eruption; AKs, Actinic keratosis; PDT, photodynamic therapy; OSCC, oral squamous cell carcinoma","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Perspectives on cancer and phytotherapy: an overview focusing on Polypodium leucotomos therapeutic properties\",\"authors\":\"P. A. Lacerda, Liliane Marinho Ottoni Costa, Guilherme Cuoghi Bellato, Lucilene Lopes-Santos, T. M. Augusto, N. Cervigne\",\"doi\":\"10.15406/JCPCR.2021.12.00448\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abbreviations: PL, Polypodium leucotomos; UV, ultraviolet radiation; DNA, desoxirribonucleic acid; HPLC, high-performance liquid chromatography; CAMs, complementary and alternative medicines; MMPs, matrix metalloproteins; ECM, extracellular matrix; TIMP metallopeptidase inhibitor; TGF-β, transforming growth factor beta; ROS reactive oxygen species; MAP kinase, mitogen-activated protein kinase; NF-κB, factor nuclear kappa B; AP-1, activator protein 1; CPD, cyclobutane pyrimidine dimer, GPx4, glutathione peroxidase 4; COX-2, ciclo-oxigenase-2; 8-MOP, 8-methoxypsoralen; 5-MOP, 5-methoxypsoralen; TNFs, tumor necrosis factors; iNOS, nitric oxide synthase; PMLE, polymorphic light eruption; AKs, Actinic keratosis; PDT, photodynamic therapy; OSCC, oral squamous cell carcinoma\",\"PeriodicalId\":15185,\"journal\":{\"name\":\"Journal of Cancer Prevention & Current Research\",\"volume\":\"15 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cancer Prevention & Current Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/JCPCR.2021.12.00448\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Prevention & Current Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JCPCR.2021.12.00448","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Perspectives on cancer and phytotherapy: an overview focusing on Polypodium leucotomos therapeutic properties
Abbreviations: PL, Polypodium leucotomos; UV, ultraviolet radiation; DNA, desoxirribonucleic acid; HPLC, high-performance liquid chromatography; CAMs, complementary and alternative medicines; MMPs, matrix metalloproteins; ECM, extracellular matrix; TIMP metallopeptidase inhibitor; TGF-β, transforming growth factor beta; ROS reactive oxygen species; MAP kinase, mitogen-activated protein kinase; NF-κB, factor nuclear kappa B; AP-1, activator protein 1; CPD, cyclobutane pyrimidine dimer, GPx4, glutathione peroxidase 4; COX-2, ciclo-oxigenase-2; 8-MOP, 8-methoxypsoralen; 5-MOP, 5-methoxypsoralen; TNFs, tumor necrosis factors; iNOS, nitric oxide synthase; PMLE, polymorphic light eruption; AKs, Actinic keratosis; PDT, photodynamic therapy; OSCC, oral squamous cell carcinoma